HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Lao People's Democratic Republic
Lao People's Democratic Republic: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) was 79.0% in 2013. ▼ Falling
Latest (2013)
79.0%
Change on year
up 1.3%
World rank
53rd
of 104 countries
All-time high
100.0%
in 2006
All-time low
76.0%
in 2011
Years of data
8
2006–2013
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Lao People's Democratic Republic, 2006–2013
Source: World Health Organization, Global Health Observatory.
Analysis
Lao People's Democratic Republic recorded 79.0% for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in 2013.
That represents a change of up 1.3% on the previous year and down 21.0% over ten years.
Lao People's Democratic Republic ranks 53rd of 104 countries on this measure, in the middle of the range.
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Lao People's Democratic Republic, year by year
| Year | Value | Change |
|---|---|---|
| 2006 | 100.0% | — |
| 2007 | 93.0% | -7.0% |
| 2008 | 98.0% | +5.4% |
| 2009 | 89.0% | -9.2% |
| 2010 | 100.0% | +12.4% |
| 2011 | 76.0% | -24.0% |
| 2012 | 78.0% | +2.6% |
| 2013 | 79.0% | +1.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 95.0% | 89.0% | 100.0% | 4 |
| 2010s | 83.2% | 76.0% | 100.0% | 4 |
Countries ranked near Lao People's Democratic Republic
- 51 Central African Republic 85.0% compare
- 52 El Salvador 84.0% compare
- 53 Uzbekistan 79.0% compare
- 53 Congo, Democratic Republic of the 79.0% compare
- 53 Gabon 79.0% compare
- 53 Honduras 79.0% compare
More health data for Lao People's Democratic Republic
- Un projection of annual infant deaths, annual growth rate -2.76 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5667 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,260 deaths per 1,000 people (2090)
- Number of infants who die before age 1 317 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 15 (2025)
- Population ages 00-04, female, annual growth rate -0.5161 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0489 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5055 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Lao People's Democratic Republic?
- Hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Lao People's Democratic Republic was 79.0% in 2013, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Lao People's Democratic Republic?
- The highest recorded value was 100.0% in 2006.
- What is the lowest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Lao People's Democratic Republic?
- The lowest recorded value was 76.0% in 2011.
- How does Lao People's Democratic Republic rank for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Lao People's Democratic Republic ranks 53rd out of 104 countries with data for 2013.
- Is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) rising or falling in Lao People's Democratic Republic?
- Over the last ten years it is down 21.0%. The long-run trend across the full record is falling.
- Where does this Lao People's Democratic Republic data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).